Regulatory News
Wednesday, July 6, 2016
BRIEF-Anaptysbio initiates multiple ascending dose cohorts in anb020 phase 1 clinical trial
* Anaptysbio initiates multiple ascending dose cohorts in
anb020 phase 1 clinical trial
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment